{"id":"W4285613832","doi":"10.17925/rmd.2022.1.1.32","title":"Belimumab: A BAFF-specific Inhibitor for the Treatment of Systemic Lupus Erythematosus and Lupus Nephritis","year":2022,"lang":"en","type":"article","venue":"touchREVIEWS in RMD","topic":"Systemic Lupus Erythematosus Research","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"ca_institutions":"AstraZeneca (Canada)","funders":"","keywords":"Belimumab; Lupus nephritis; B-cell activating factor; Medicine; Immunology; Systemic lupus erythematosus; Hydroxychloroquine; Lupus erythematosus; Internal medicine; Antibody; Disease; B cell","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007584268,0.0004914344,0.0005490036,0.001106324,0.0003238749,0.0006789167,0.0004565922,0.0009012755,0.003036305],"category_scores_gemma":[0.0006088701,0.0001647506,0.0004751056,0.0007374075,0.0003683771,0.0007616248,0.0004877781,0.001816771,0.002160486],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005996082,"about_ca_system_score_gemma":0.0005237173,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0003700582,"about_ca_topic_score_gemma":0.0009050639,"domain_scores_codex":[0.9996687,0.00008055561,0.00003136861,0.00003790241,0.0001277948,0.00005368438],"domain_scores_gemma":[0.9997669,0.00006511011,0.00004643808,0.000008259198,0.00004840996,0.0000649254],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0003749633,0.0001881172,0.0004771975,0.002690847,0.0001104456,0.0004230787,0.00007659796,0.000155143,0.009708813,0.002197088,0.08984187,0.8937558],"study_design_scores_gemma":[0.0001686982,0.0004276508,0.001999123,0.0006211072,0.00009091329,0.002548873,0.00003258381,0.00008182107,0.002533847,0.0008549739,0.9906207,0.00001964749],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.001927791,0.9873656,0.0005829872,0.00409324,0.001796773,0.00002903256,0.00004743792,0.00007955327,0.004077502],"genre_scores_gemma":[0.01511444,0.9663289,0.001705245,0.005195378,0.003683168,0.00005082714,0.0002546852,0.00002272859,0.007644654],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.003036305,"threshold_uncertainty_score":0.01015741,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.04446576391625988,"score_gpt":0.3116049861882569,"score_spread":0.267139222271997,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}